Synthesis and antioxidant activity of vitamin C analogs and vitamin E analogs
Synthesis and antioxidant activity of vitamin C analogs and vitamin E analogs
批准号:
11672217
负责人:
MASHINO Tadahiko
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
活性氧(ROS)和自由基诱导氧化应激,并在人类疾病如癌症的发生和/或进展中起重要作用。因此,抗氧化剂有望成为一种良好的药物先导化合物。在这项研究中,我们开发了基于维生素C和E.1的优秀抗氧化剂。设计并合成了苯并[h]色满类化合物(BC),用ESR自旋捕捉法研究了BC对超氧阴离子和OH自由基的猝灭活性。这两种活性均高于维生素E水溶性类似物trolox.维生素C类似物还原酸(RA)是一种在5元碳环上有一个羰基与2,3-烯醇共轭的化合物。RA抑制黄嘌呤氧化酶的活性,而抗坏血酸没有。RA淬灭自由基,并减少活性氧的产生。黄嘌呤氧化酶产生尿酸,尿酸在山羊体内起重要作用。因此,黄嘌呤氧化酶抑制剂可作为山羊的药物。RA被认为是一种很有前途的氧化应激抑制剂和山羊的治疗药物。我们的数据表明,BC和RA是一个新的起始结构,用于设计抗肿瘤的化合物,如癌症。
英文摘要
Reactive oxygen species (ROS) and free radicals induce oxidative stress and play the important role in developing and/or progression of human diseases such as cancer. So, antioxidants are expected to be a good lead compounds for medicines. In this study, we developed excellent antioxidants based vitamin C and E.1. Vitamin E analogsWe designed and synthesized benzo[h]chroman compounds (BC) which had benzene ring fused with vitamin E skelton and examined superoxide and OH radical quenching activity by ESR spin-trapping methods. Both activities were higher than that of trolox, which is vitamin E water-soluble analog.2. Vitamin C analogsReductic acid (RA) which has a 2,3-enediol moiety conjugated with a carbonyl group in a five-membered carbon ring was synthesized. RA inhibited xanthine oxidase activity, while ascorbic acid did not.RA quenched free radicals and also decreases active oxygen production. RA is thought to be a more potent inhibitor of active oxygen toxicity than ascorbic acid.Xanthine oxidase produces uric acid, which plays a crucial role in goat. Therefore, xanthine oxidase inhibitor works as a medicine for goat. RA is thought to be a promising inhibitor for oxidative stress and remedy for goat.Our data showed that BC and RA serves as a new starting structure for the design of pharmacologically effective compounds such as cancer.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Xanthine oxidase阻害活性を有する抗酸化剤の開発.
开发具有黄嘌呤氧化酶抑制活性的抗氧化剂。
DOI:
--
发表时间:
2000
期刊:
影响因子:
--
作者:
[滝川靖, 増野匡彦, 他]
通讯作者:
他
Antioxidant activity and xanthine oxidase inhibition activity of reductic acid ; ascorbic acid analog.
还原酸的抗氧化活性和黄嘌呤氧化酶抑制活性;
DOI:
--
发表时间:
2000
期刊:
Bioorg. Med.Chem.Lett. 10
影响因子:
--
作者:
[T.Mashino, et at]
通讯作者:
et at
Antioxidant activity and xanthine oxidase inhibition activity of reductic acid ; ascorbic acid skeleton analog.
还原酸的抗氧化活性和黄嘌呤氧化酶抑制活性;
DOI:
--
发表时间:
2000
期刊:
影响因子:
--
作者:
[T.Mashino, et al.]
通讯作者:
et al.
Antioxidant activity and xanthine oxidase inhibition activity of reductic acid ; ascorbic acid skeleton analog
还原酸的抗氧化活性和黄嘌呤氧化酶抑制活性;
DOI:
--
发表时间:
2000
期刊:
影响因子:
--
作者:
[T.Mashino, et al.]
通讯作者:
et al.
キサンチンオキシダーゼ阻害活性を有するアスコルビン酸類縁体の開発.
开发具有黄嘌呤氧化酶抑制活性的抗坏血酸类似物。
DOI:
--
发表时间:
1999
期刊:
影响因子:
--
作者:
[増野匡彦, 他]
通讯作者:
他
共 8 条
Development of novel antimicrobial agent with the fullerene skeleton
-
批准号:13672327
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2001
-
负责人:MASHINO Tadahiko
-
依托单位:
国内基金
海外基金
Vitamin E抑制胞浆APE1/Beclin1信号途径克服肺癌EGFR T790M突变耐药及机制研究
-
批准号:81802292
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张志敏
-
依托单位:
Vitamin E脂质体纳米颗粒携带siRNA靶向抑制HCV的实验研究
-
批准号:81171628
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:陈维贤
-
依托单位: